Advertisement


Charles B. Simone, II, MD, on NSCLC: CTCs as a Biomarker for Early Detection

2017 Multidisciplinary Thoracic Cancers Symposium
Tweet this page

Charles B. Simone, II, MD, of the University of Maryland Medical Center, discusses results from a large prospective study in locally advanced non–small cell lung cancer, which suggest that circulating tumor cells may be a promising biomarker of progressive or recurrent disease and may help guide early salvage treatment strategies (Abstract 3).

Advertisement

Advertisement



Advertisement

click me